Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses

Gut

Volumn 44, Issue 4, 1999, Pages 519-526

  Yang, H ^a,b   Plevy, S E ^a   Taylor, K ^a   Tyan, D ^a   Fischel Ghodsian, N ^a   McElree, C ^a   Targan, S R ^a   Rotter, J I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; Genetics; HLA; Inflammatory bowel disease; Linkage; Tumour necrosis factor

Indexed keywords

HLA ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR;

ARTICLE; CHROMOSOME 6; CONTROLLED STUDY; CROHN DISEASE; GENE LOCUS; GENETIC LINKAGE; HAPLOTYPE; HUMAN; HUMAN CELL; JEW; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SIBLING;

EID: 0032926240     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.4.519     Document Type: Article

References (52)

1. Yang H, Rotter JI. Genetic aspects of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Baltimore: Williams and Wilkins, 1995:301-31.
2. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 1988;29:990-6.
3. Fujita K, Naito S, Okabe N, et al. Immunological studies in Crohn's disease. I. Association with HLA systems in Japanese. J Clin Lab Immunol 1984;14;99-102.
4. Kobayashi K, Atoh M, Yagita A, et al. Crohn's disease in the Japanese is associated with the HLA-DRw53. Exp Clin Immunogenet 1990;7:101-8.
5. Toyoda H, Wang S-J, Yang H, et al. Distinct association of HLA class II gene with inflammatory bowel disease. Gastroenterology 1993;104:741-8.
6. Danze PM, Colombel JF, Jacquot S, et al. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 1996;39:69-72.
7. Forcione DG, Sands B, Isselbacher KJ, et al. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci USA 1996;93:5094-8.
8. Reinshagen M, Loeliger C, Kuehnl P, et al. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut 1996;38:538-42.
9. van Dullemen HM, van Deventer SJ, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
10. Targan SR, Hanauer SB, van Deventer SJH, et al. A short-term study of anti-tumor necrosis factor-alpha chimeric monoclonal antibody (cA2) in Crohn's disease. N Engl J Med 1997;337:1029-35.
11. Plevy SE, Targan SR, Yang H, et al. Tumor necrosis factor microsatellites define a Crohn's disease associated haplotype on chromosome 6. Gastroenterology 1996;110:1053-60.
12. Louis E, Satsangi J, Roussomoustakaki M, et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996;39:705-10.
13. Bouma G, Poen A, Garcia-Gonzalez MA, et al. HLA-DRB1*03, but not the TNFA-308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics 1998;47:451-5.
14. Schwartz SE, Siegelbaum SP, Fazio TL, et al. Regional enteritis evidence for genetic transmission by HLA typing. Ann Intern Med 1980;93:424-7.
15. Achord JF, Gunn GH, Jackson JF. Regional enteritis and HLA concordance in multiple siblings. Am J Hum Genet 1982;27:330-2.
16. Purrmann J, Miller B, Lapsien B, et al. HLA haplotype study in familial Crohn disease. Zeitschrift fur Gastroenterologie 1985;23:432-7.
17. Kuhnl P, Sibrowski W, Bohm BO, et al. HLA antigen frequencies in familial Crohn's disease (CD). Beitr Infusionsther 1990;26:284-6.
18. Pena AS, Biemond I, Weterman IT, et al. HLA antigen distribution and HLA haplotype segregation in Crohn's disease. Tissue Antigens 1980;16:56-61.
19. Eade OE, Moulton C, MacPherson BR, et al. Discordant HLA haplotype segregation in familial Crohn's disease. Gastroenterology 1980;79:271-5.
20. Colombel JF, Guillemot F, Gossum AV, et al. Familial Crohn's disease in multiple siblings: no linkage to the HLA system. Gastroenterol Clin 1989;13:676-8.
21. Hugot J-P, Laurent-Puig P, Gower-Rousseau C, et al. Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. Am J Med Genet 1994;51:1-8.
22. Naom I, Lee J, Ford D, et al. Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am J Hum Genet 1996;59:226-33.
23. Satsangi J, Welsh KI, Bunce M, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996;347:1212-17.
24. Yang H, McElree C, Roth M-P, et al. Familial empiric risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993;34:517-24.
25. Nakajima A, Matsuhashi N, Kodama T, et al. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995;109:1462-7.
26. Risch N. Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 1990;46:229-41.
27. Bishop DT, Williamson JA. The power of identity-by-state methods for linkage analysis. Am J Hum Genet 1990;46:242-65.
28. Yang H, Rotter JI. The genetics of inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins, 1994:32-64.
29. Hugot J-P, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16 by a genome-wide nonparametric linkage analysis. Nature 1996;379:821-3.
30. Ohmen JD, Yang H, Yamamoto KK, et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet 1996;5:1679-83.
31. Vasiliauskas EV, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies (pANCA) in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996;110:1810-19.
32. Yang H, Rotter JI, Toyoda H, et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (anti-neutrophil cytoplasmic antibodies) markers. J Clin Invest 1993;92:1080-4.
33. Redford A, Magalong D, Onohara-Toyoda M, et al. Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta gene associated with DNA fragment identical to the DR1-beta gene DNA structure. Dis Markers 1991;9:257-63.
34. Udalova IA, Nedospasov SA, Webb GC, et al. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993;16:180-6.
35. Spies T, Morton CC, Nedospasov SA, et al. Genes for the tumor necrosis factors a and b are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 1986;83:8699-702.
36. Carroll MC, Katzman P, Alicot EM, et al. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 1987;84:8535-9.
37. Dunham I, Sargent CA, Trowsdale J, et al. Molecular mapping of the human major histocompatibility complex by pulse-field gel electrophoresis. Proc Natl Acad Sci USA 1987;84:7237-41.
38. Lizak GE, Grumet FC. A new micromethod for the in vitro detection of antiplatelet antibodies: C-FDA thrombocytotoxicity. Hum Immunol 1980;1:87-96.
39. Tyan DB, Li VA, Czer L, et al. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994;57:553-62.
40. Hashimoto L, Habita C, Beressi JP, et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994;371:161-4.
41. SAGE. Statistical Analysis for Genetic Epidemiology, Release 3.0. Computer program available from the Department of Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, MetroHealth Campus. 3rd edn. Cleveland: Case Western Reserve University, 1997.
42. Tran LD, Elston RC, Keats BJB, et al. Sib pair linkage program (SIBPAL) user's guide. Part of the SAGE Release 3.0 documentation, Department of Epidemiology and Biostatistics, Case Western Reserve University, 1997.
43. Cantor RM, Rotter JI. Marker concordance in pairs of distant relatives: a new method to detect genetic heterogeneity. Clin Res 1988;36:A184.
44. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987;40:1-14.
45. Rotter JI, Landaw EM. Measuring the genetic contribution of a single locus to a multilocus disease. Clin Genet 1984;26:529-42.
46. Calkins BM, Mendeloff AI. The epidemiology of idiopathic inflammatory bowel diease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Baltimore: Williams and Wilkins, 1995:31-68.
47. Erlich H, Zeidler A, Chang J, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nature Genetics 1993;3:358-64.
48. Satsangi J, Parkes M, Louis E, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genetics 1996;14:199-202.
49. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
50. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
51. Mombaerts P, Mizoguchi E, Grusby MJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:275-82.
52. Cho JH, Fu Y, Kirschner BS, et al. Confirmation of a susceptibility locus for Crohn's disease on chromosome 16. Inflammatory Bowel Disease 1997;3:186-90.